Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritis
Clicks: 234
ID: 112676
2014
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate (MTX), a synthetic disease-modifying anti-rheumatic drug (sDMARD) and biological DMARDs (bDMARDs) …
| Reference Key |
y2014drugsintensive
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tanaka Y;Hirata S;; |
| Journal | drugs |
| Year | 2014 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
arthritis
pmid:25389048
pmc4245498
doi:10.1007/s40265-014-0323-4
yoshiya tanaka
shintaro hirata
antirheumatic agents / pharmacology*
rheumatoid* / drug therapy
rheumatoid* / physiopathology
immunosuppressive agents / pharmacology
medication therapy management / trends
methotrexate / pharmacology
patient acuity
remission induction / methods*
withholding treatment / trends*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.